Bioxalis Medica is developing targeted liposomes for cancer treatment.

History:

Gelkem changed their name to Bioxalis Medica before being acquired by Procyon BioPharma in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
North America

Research Focus:
Disease Therapeutics-Research Therapeutics-Development

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: